In xenograft models, BBC3 knockdown compromised the antitumor efficacy of AQB+CBPt, as evidenced by accelerated tumor growth and higher Ki-67 staining compared with controls (Supplementary Fig. S7G–K). Here, BBC3 is linked to neoplasm.